EDSP’s Approach to Test Protocol Validation Office of Science Coordination and Policy U.S. Environmental Protection Agency.

Slides:



Advertisements
Similar presentations
ENTITIES FOR A UN SYSTEM EVALUATION FRAMEWORK 17th MEETING OF SENIOR FELLOWSHIP OFFICERS OF THE UNITED NATIONS SYSTEM AND HOST COUNTRY AGENCIES BY DAVIDE.
Advertisements

EPAA Annual conference November Regulatory acceptance of alternative approaches for pharmaceuticals Jean-Marc Vidal Safety & Efficacy of Human Medicines.
Regulatory Acceptance of Alternative Methods- Pharmaceuticals in the U.S. A. Jacobs 11/07 (not an official opinion)
Perspectives from EPA’s Endocrine Disruptor Screening Program
Program Management Office (PMO) Design
Pubertals and One-generation Extension. Overview of questions Does the fire raise significant concerns? Should the EPA bring the pubertal and one-gen.
UNEP Advisory Group Meeting Geneva, Switzerland December 12, 2014
Richard A. Becker, Ph.D., D.A.B.T American Chemistry Council Arlington, Virginia Comments on “Dose Setting” EDMVS Meeting July 23-24, 2002.
1 High Production Volume (HPV) Challenge Program Diane Sheridan Chief, Existing Chemicals Branch, Chemical Control Division, Office of Pollution Prevention.
Priority-setting for the Endocrine Disruptor Screening Program: Pesticide Active Ingredients Penelope A. Fenner-Crisp Office of Pesticide Programs U.S.
National Pesticide Program A New Toxicology Testing Paradigm: Meeting Common Needs Steven Bradbury, Director Environmental Fate and Effects Division Office.
CFSAN’s Peer Review for Risk Assessments Robert L. Buchanan, Sherri Dennis, and Marianne Miliotis.
Lessons Learned in Initiating and Conducting Risk Assessments within a Risk Analysis Framework: A FDA/CFSAN Approach Robert Buchanan DHHS Food and Drug.
EDSP Validation Gary E.Timm Senior Technical Advisor Office of Science Coordination and Policy U.S. Environmental Protection Agency.
NSF/ANSI STANDARD 61 FRAMEWORK FOR RISK ASSESSMENTS For use by Toxicology Sub-committee only Please do not copy or distribute.
ESPA Comprehensive Aquifer Management Plan Presentation to the Governor’s Water Summit April 17, 2007 Idaho Water Resource Board Jonathan Bartsch and Diane.
Evolution of ICCVAM ◊National Toxicology Program Develop and validate improved test methods ◊NIH Revitalization Act: P.L Develop and.
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
Characterizing Chemical in Commerce: Using Data on High Production Volume (HPV) Chemicals December 12, 2006 L. Twerdok, Ph.D, DABT NPPTAC Member Report.
Quill Law Group LLC1 EDSP Implementation Business and Legal Considerations Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
1 Delta Levees Investment Strategy Delta Stewardship Council Central Valley Flood Protection Board Levees Workshop July 10, 2015.
Status of the U.S. Endocrine Disruptor Screening Program (EDSP) Status of the U.S. Endocrine Disruptor Screening Program (EDSP) September
Nanomaterials Issue Paper Standard 61 Joint Committee Meeting December, 2013.
Office of Pesticide Programs 21st Century Screening Assessment of Pesticides – A Regulatory View Vicki Dellarco, Ph.D. Senior Science Advisor Office of.
Quality assurance activities at EUROSTAT CCSA Conference Helsinki, 6-7 May 2010 Martina Hahn, Eurostat.
U.S. High Production Volume (HPV) Challenge Program Diane Sheridan U.S. Environmental Protection Agency October 25, 2005 Region 2 Emerging Chemicals Workshop.
Jeff Morris Associate Director for Science Office of Science Policy Symposium on Peer Review of Risk Assessments and Related Activities September 30, 2003.
The Report of the Provost’s Advisory Group on the SUNY Assessment Initiative September 2009 Tina Good, Ph.D. President Faculty Council of Community Colleges.
Quill Law Group LLC1 EDSP Compliance Timing, Procedural and Legal Issues Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Slide 1 of 24 EPA’s Endocrine Disruptor Screening Program (EDSP) Use of Exposure Data in Priority Setting Bill Wooge Office of Science Coordination and.
Progress on Coordinating CBP and Federal Leadership Goals, Outcomes, and Actions Principals’ Staff Committee Meeting 2/16/12 Carin Bisland, Associate Director.
United States Department of Agriculture Food Safety and Inspection Service 1 National Advisory Committee on Meat and Poultry Inspection August 8-9, 2007.
Forging Partnerships on Emerging Contaminants November 2, 2005 John Vandenberg Associate Director for Health National Center for Environmental Assessment.
1 Tier 1 EDSP: Other Scientifically Relevant Information Barbara Neal Exponent December 13, 2010.
Presented by: Louise Desjardins, M.Sc., Ph.D. Executive Director December 3, 2014.
Division Of Early Warning And Assessment MODULE 5: PEER REVIEW.
Wildlife Screens What Do They Tell Us? Dr. Pat Guiney Manager Global Safety, Regulatory & Environmental Assessment S.C. Johnson & Son, Inc. Racine, WI.
IAEA International Atomic Energy Agency. IAEA Outline LEARNING OBJECTIVES REVIEW TEAM AND COUNTERPARTS Team Composition Qualification PREPARATORY PHASE.
RIA: Communication – building credibility Aleš Pecka Department of Regulatory Reform and Public Administration Quality Ministry of Interior, Czech Republic.
1 New NAAQS Review Process Briefing for EPA Staff Kevin Teichman, ORD and Lydia Wegman, OAQPS April 5, 2007.
NOAA Science Advisory Board …advises the Secretary of Commerce for Oceans and Atmosphere on long- and short- range strategies for research, education,
The Codex Alimentarius Commission
International Society of Regulatory Toxicology and Pharmacology 2009 Endocrine Workshop The Endocrine Disruptor Screening Program: What Can Screening Results.
FAO/WHO Codex Training Package Module 4.2 JOINT FAO/WHO CODEX TRAINING PACKAGE MODULE FOUR – SCIENTIFIC BASIS FOR CODEX WORK 4.2 Requesting, accessing.
FAO/WHO Codex Training Package Module 4.3 FAO/WHO CODEX TRAINING PACKAGE SECTION FOUR – SCIENTIFIC BASIS FOR CODEX WORK 4.3 What is JECFA?
Development of a Common Effects Methodology for OW and OPP EPA Development Team Office of Pesticide Programs Office of Water Office of Research and Development.
1. Particulate Matter (Air Pollutants) Webinar presentation January 9, 2014 Marc Deslauriers Environment Canada Environmental Stewardship Branch.
Quill Law Group LLC1 EDSP Implementation Business and Legal Considerations Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
Introduction to Session II: Incorporating Existing Data into the EDSP Erik R. Janus Director, Human Health Policy CropLife America.
International Atomic Energy Agency Regulatory Review of Safety Cases for Radioactive Waste Disposal Facilities David G Bennett 7 April 2014.
NDIA PMCS May Rosslyn, VA Earned Value Management System Acceptance Working Group Buddy Everage Working Group Lead.
Prioritization Process and Development of the Hazard Characterization Documents Office of Pollution Prevention and Toxics U.S. Environmental Protection.
IAEA International Atomic Energy Agency. IAEA Outline LEARNING OBJECTIVES REVIEW TEAM AMD COUNTERPARTS Team Composition Qualification PREPARATORY PHASE.
Legacy Report of Select Committee on Finance By: Zolani Rento Date: 09 July 2014.
Science Symposium, 26 May 2014, New Delhi, India Dr Gerald Renner Director Technical Regulatory Affairs Cosmetics Europe EU scenario on alternatives in.
EDSP Implementation: Concerns for the Pesticide Industry ISRTP 2009 Endocrine Workshop: The Endocrine Disruptor Screening Program: What Can Screening Results.
Harmonised use of accreditation for assessing the competence of various Conformity Assessment Bodies Dr Andreas Steinhorst, EA ERA workshop 13 April 2016,
EIAScreening6(Gajaseni, 2007)1 II. Scoping. EIAScreening6(Gajaseni, 2007)2 Scoping Definition: is a process of interaction between the interested public,
Work Plan Work Plan Management (Document 21)
New Ecological Science Advice for Ecosystem Protection The EPA Science Advisory Board (SAB) Staff Office supports three external scientific advisory committees.
Safe Drinking Water Act , CCL and Perchlorate
The Codex Alimentarius Commission
RIA: Communication – building credibility
Setting Actuarial Standards
ECVAM as EU-RL according to 2010/63
Comments on Using Existing Data for the Endocrine Screening Testing Lorenz Rhomberg, PhD Principal Gradient ISRTP 2009 Endocrine Workshop.
JRC support to EC work on endocrine disrupters
Stakeholder Engagement: Webinar Part I: The Regulatory Development Process for the Government of Canada Part II: Making Technical Regulations Under.
Topic 2 – Reform Documents 4(4) and 4(5)(Cg-18)
Dr. Phyllis Underwood REL Southeast
Presentation transcript:

EDSP’s Approach to Test Protocol Validation Office of Science Coordination and Policy U.S. Environmental Protection Agency

Validation Process Statutory Requirements EPA must use valid screens and tests in the EDSP (FQPA) The EDSP must be reviewed by the FIFRA Scientific Advisory Panel or Scientific Advisory Board (FQPA)

Process Realities for EDSP Stakeholder involvement throughout the process Challenge to make process open and under the FACA procedures Follow ICCVAM process for validation of test protocols Need to develop valid test guidelines

Process Realities for EDSP International harmonization of guidelines through OECD Deadlines established in NRDC settlement agreement Deadlines in appropriations process

Validation Process Stakeholder Involvement Standardization and Validation Task Force –Technical group made up of major stakeholders formed after EDSTAC –3 expert workgroups: in vitro, mammalian, ecotoxicity –Challenge resulted in disbandment of SVTF –Replaced by a FACA committee EDMVS –Will advise EPA on standardization and validation issues

ICCVAM Validation Process 1. Method Development 2.Prevalidation Demonstration of relevance Standardization of protocol 3.Validation in multiple laboratories 4.Scientific Peer Review 5. Regulatory acceptance and implementation

Challenge: How to Meet Conflicting Requirements Guidelines of international interest to be developed and validated under OECD auspices Domestic guidelines requiring lab work to be developed and validated by EPA with advice from EDMVS ER/AR binding assay, not requiring lab work, to be validated by ICCVAM.

Lead Organization for Validation EPAOECDICCVAM ER AR BindingX SteroidogenesisX AromataseX UterotrophicX HershbergerX

Lead Organization for Validation EPAOECDICCVAM Pubertal femaleX Pubertal maleX Fish Repro ScreenX In uterolactationX

Lead Organization for Validation TestEPAOECDICCVAM Mammalian? AvianX FishX AmphibianX Invertebrate?

EPA Process for Domestic Guidelines For domestic test guidelines, follow ICCVAM Process with EPA administration EDMVS will advise EPA on design and execution of validation work and validation products EPA will conduct literature reviews and laboratory work for methods development, pre-validation and validation through Contractor

EPA Process for Domestic Guidelines Involve ICCVAM through representation on FAC, consult with ICCVAM between pre-validation and validation and give opportunity to comment at peer review Conduct independent peer review

Process for Domestic Guidelines FAC EPA -Method development -Prevalidation -Validation SAP/SAB - Peer Review Stakeholder advice Consultation ICCVAM - Consultation -Recommend peer reviewers -Comments to SAP/SAB Contractor

Process for International Guidelines Follow ICCVAM requirements OECD’s Endocrine Disruptor Testing and Assessment workgroup will be primary vehicle for deliberation and stakeholder input EDMVS kept informed and will be asked for input for US position

Process for International Guidelines US will be lead country on most guidelines –Lead country coordinates technical work –US volunteering for lead country because we have resources and are mandated to meet schedule Peer review National Coordinator comment process

OECD Test Guideline Process MC Scientific Com Secretariat Natl Coord Natl Coord Mtg Detailed Review Paper * Comment Test Guideline** Expert Mtg Proposed Changes Test GuidelineApproval by Natl Coord Joint Mtg EPOC Council Published Guideline

OECD ED Test Guideline Roles EDTA- Government and major stakeholders VMG-Eco-Technical experts VMG-Mam-Technical experts TEST GUIDELINE PROGRAM National Coordinators

KEY CONCEPTS IN EPA VALIDATION APPROACH Select chemicals specific to each assay, validate assay rather than battery More chemicals in pre-validation to establish relevance of assay and standardize the protocol than in validation phase Battery validation will be a paper exercise that relies on test results of individual assays

EPAValidation Process Method development and preparation of Detailed Review Paper (DRP) Pre-validation –Demonstration of relevance –Development of standardized protocol Determination of readiness for validation in consultation with EDVMS and ICCVAM Validation in multiple laboratories Independent peer review and review by ICCVAM

Detailed Review Paper 1.0 Executive Summary 2.0 Introduction 2.1 EDSP 2.2 Validation process 2.3 Purpose of DRP 2.4 Objective of the assay 2.5 Methodology used in the analysis

Detailed Review Paper 3.0 Scientific Basis of the Assay 4.0 Candidate Protocols 5.0 Implementation Considerations 5.1 Technical requirements 5.2 Cost/time requirements 5.3 Animal welfare considerations

Detailed Review Paper 6.0 Recommended Protocol 7.0 Developmental Status of the Assay 7.1 Current status 7.2 Uncertainties, protocol issues needing resolution and data needs 7.3 Recommendation for further development and pre-validation studies 8.0 References

Pre-Validation Report 1.0 Pre-validation Study Plan 1.1 Endpoints of interest 1.2 Protocol issues needing resolution 1.3 Study design to address outstanding issues 1.4 Test substances and dose selection 1.5 Detailed protocol(s)

Pre-Validation Report 2.0 Pre-validation Study Results 3.0 Assessment of Test Method 4.0 Standardized Protocol 5.0 References

Validation Report 1.0 Validation study plan 1.1 Protocol 1.2 Selection of laboratories 1.3 Test substances and dose selection 2.0 Validation Study Results 3.0 Test Method Data Quality

Validation Report 4.0 Assessment of Test Method 5.0 Animal Welfare Considerations 6.0 Proposed Test Guideline 7.0 References

Summary Report 1.0 Introduction and Rationale for the Proposed Method 2.0 Proposed Test Method Protocol 3.0 Characterization of the Materials Tested 4.0 Reference Data Used for Performance Assessment 5.0 Test Method Data and Results 6.0 Test Method Performance Assessment 7.0 Test Method Reliability 8.0 Test Method Data Quality 9.0 Other Scientific Reports and Reviews 10.0 Animal Welfare Considerations 11.0 Other Considerations